ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 479,40
-0,68%
Dow Jones
39 118,86
-0,12%
DAX
18 235,45
0,17%
Brent Oil
84,85
0,00%
Bitcoin
60 743,33
0,72%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. GeoVax Labs Inc (GOVX)

  7. GeoVax Labs Inc (GOVX) Actualités

GOVX

GeoVax Labs (GOVX)

GeoVax Labs Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:GOVX
DateHeureSourceTitreSymboleSociété
04/04/202418h30GlobeNewswire Inc.GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 VaccineNASDAQ:GOVXGeoVax Labs Inc
28/03/202414h00GlobeNewswire Inc.GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine CongressNASDAQ:GOVXGeoVax Labs Inc
12/03/202414h00GlobeNewswire Inc.GeoVax to Present at the 36th Annual Roth ConferenceNASDAQ:GOVXGeoVax Labs Inc
11/03/202421h13Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:GOVXGeoVax Labs Inc
11/03/202405h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GOVXGeoVax Labs Inc
06/03/202415h00GlobeNewswire Inc.GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing SystemNASDAQ:GOVXGeoVax Labs Inc
01/03/202422h08Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:GOVXGeoVax Labs Inc
29/02/202422h05Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:GOVXGeoVax Labs Inc
29/02/202422h00GlobeNewswire Inc.GeoVax Reports 2023 Year-End Financial Results and Provides Business UpdateNASDAQ:GOVXGeoVax Labs Inc
22/02/202422h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GOVXGeoVax Labs Inc
22/02/202415h00GlobeNewswire Inc.GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024NASDAQ:GOVXGeoVax Labs Inc
19/02/202415h00GlobeNewswire Inc.GeoVax to Present at the 2024 BIO CEO & Investor ConferenceNASDAQ:GOVXGeoVax Labs Inc
16/02/202422h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOVXGeoVax Labs Inc
14/02/202421h38Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:GOVXGeoVax Labs Inc
13/02/202415h00GlobeNewswire Inc.GeoVax Announces Multiple Patent Issuances and AllowancesNASDAQ:GOVXGeoVax Labs Inc
06/02/202415h00GlobeNewswire Inc.GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine BoosterNASDAQ:GOVXGeoVax Labs Inc
29/01/202415h00GlobeNewswire Inc.GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid RequirementNASDAQ:GOVXGeoVax Labs Inc
12/01/202422h00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:GOVXGeoVax Labs Inc
08/01/202415h00GlobeNewswire Inc.GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, OncologyNASDAQ:GOVXGeoVax Labs Inc
04/01/202415h00GlobeNewswire Inc.GeoVax Announces Gedeptin® Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer PatientsNASDAQ:GOVXGeoVax Labs Inc
03/01/202415h00GlobeNewswire Inc.GeoVax Announces Issuance of Malaria Vaccine PatentNASDAQ:GOVXGeoVax Labs Inc
02/01/202422h10Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:GOVXGeoVax Labs Inc
27/12/202315h00GlobeNewswire Inc.GeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2024NASDAQ:GOVXGeoVax Labs Inc
19/12/202315h00GlobeNewswire Inc.GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and SmallpoxNASDAQ:GOVXGeoVax Labs Inc
30/11/202322h30GlobeNewswire Inc.GeoVax Hemorrhagic Fever Vaccine Data Presented at World Vaccine CongressNASDAQ:GOVXGeoVax Labs Inc
29/11/202315h00GlobeNewswire Inc.GeoVax to Participate in Upcoming December Investor EventsNASDAQ:GOVXGeoVax Labs Inc
28/11/202315h00GlobeNewswire Inc.GeoVax COVID-19 Vaccine Clinical Data Presented at World Vaccine CongressNASDAQ:GOVXGeoVax Labs Inc
27/11/202322h06Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:GOVXGeoVax Labs Inc
17/11/202322h27Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:GOVXGeoVax Labs Inc
14/11/202315h00GlobeNewswire Inc.Progress on GeoVax’s Universal Coronavirus Vaccine Candidate, GEO-CM02, Presented at Vaccines Summit 2023NASDAQ:GOVXGeoVax Labs Inc
 Showing the most relevant articles for your search:NASDAQ:GOVX

Dernières Valeurs Consultées

ASX
CHCKOB
NASDAQ
TXCXX
Tax-Exempt California Money Mark
EU
BELAS
Brussels All Shares Price
AMEX
FCL
TG
A3KWSE
MPT Operating Partnership
EU
BNBA
21Shares Binance Coin ETP
NYSE
RTN
Raytheon
BTRX
TONUSDT
Wrapped TON Coin
TSX
CIF
iShares Global Infrastru...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés